Edit |   |
---|---|
Antigenic Specificity | CD261, Human (Mapatumumab biosimilar) |
Clone | Mapatumumab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG1 |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | Neut, ELISA, IF, IP, FuncS, FCM, IHC |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human CD261 Recombinant Antibody. Mapatumumab (HGS-ETR1) is an experimental human monoclonal antibody undergoing clinical trials for the treatment of cancer. It targets TRAIL-R1, also known as DR4, which is expressed on the surface of many tumor cell types. |
Immunogen | n/a |
Other Names | Anti-CD261 Recombinant Antibody, Research Grade Mapatumumab, Anti-Human CD261 Recombinant Antibody, HGS-ETR1, TRM-1, Antibody Drug Analogues, Monoclonal Antibody, YR1119, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 658052-09-6 |
Catalog # | YR1119 |
Price | please inquire |
Order / More Info | CD261, Human (Mapatumumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |